Alternative regimens of anti-VEGF therapy for neovascular AMD, variable treatment in particular, have become the de facto clinical practice. Their wide adoption is based on a tacit belief in their ...

Two complement inhibitors tied to increased risk of wet AMD, but data called suspect ...

"It is not necessary to measure the extent, height, or length of the DLS [double layer sign]. It is sufficient to know, however, that when DLS is seen that it’s a key risk factor and that regular ...

VANCOUVER, Canada — Optical coherence tomography (OCT) angiography can help predict which eyes affected by age-related macular degeneration are most likely to develop exudation, research shows. The ...

Patients using GLP-1 receptor agonists appear to have a lower risk of age-related macular degeneration and primary open-angle glaucoma. Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) ...

Researchers have found in a prospective study of 550 cases that the double-layer sign on optical coherence tomography (OCT), commonly used in the fellow eye of patients with ...

Patients with age-related macular degeneration (AMD) initially may present with distortions in fine visual perception, and disease may be asymptomatic. As the disease develops over time, vision ...

A real-world analysis suggests complement inhibitors for geographic atrophy may raise risks of exudative age-related macular degeneration, subfoveal GA progression, and vision loss, with statistical ...

Age-related macular degeneration (AMD) has a worldwide incidence of between 30 and 50 million people and is expected to affect up to 288 million people by the year 2040. Globally, AMD constitutes 6% ...